Clinical Trial Update: Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial of ozanezumab vs placebo in amyotrophic lateral sclerosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Ozanezumab (ozanezumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-19